Main Industry
Biotechnology
Main Product/Service
The "NT carry+ Biomimetic Microcarrier Automated Loading Equipment" developed by Nyhet International Co., Ltd. is dedicated to enabling cell transportation at ambient temperature, making the impossible possible. It disrupts the traditional limitations of requiring low-temperature transport, while also significantly reducing cell loss and damage caused by collisions during the transportation process.
The content above was translated by Ai
Founded Year
2017
Unified Business No.
69734507
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,530,000 (NT$)
Location of Company
Taiwan
, Taoyuan City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
"Discovering expertise, realizing expertise, and applying expertise"—journeying from a personal dream to team R&D and company operations, the team of Nyhet International Co., Ltd. has, since 2015, always taken caring for life as its starting point, insisting on using expertise and technology to solve critical problems in life and address gaps in the industry. Meanwhile, the global cell market has been booming since 2017, with major international manufacturers investing massive resources into research and development, particularly in therapies related to human diseases (such as T-cell therapy, NK cell therapy, etc.), thereby gradually building up the entire industry chain. Within this industry chain, Nyhet International Co., Ltd. also plays the role of a professional service and tool provider, focusing on building a cell culture platform and further investing in research related to cell culture and carriers, which will provide an indispensable tool in the transportation process of the cell industry, making cell transportation more accessible and convenient.
In 2018, Nyhet International Co., Ltd. successively conducted R&D experiments on cell encapsulation viability and other areas with domestic medical universities, establishing the capacity of NT carry+ technology (cell biomimetic carrier) and achieving an innovative model that allows cells to be transported at room temperature; meanwhile, in 2019, the company defined various specifications of the NT carry+ technology, while simultaneously developing related technologies and branding with its technical team. In 2020, the company was honored with the "17th National Innovation Award - Startup Company," receiving high recognition. Nyhet International Co., Ltd. not only possesses robust R&D capabilities but also promotes the application of this technology in the life science fields of pet medical care and medical beauty and skincare. The company actively strives to be not just a biomedical company with a high price-to-dream ratio, but an innovative enterprise where technology is solidly implemented, becoming the most valuable provider in this industry chain. This allows development strategies at different stages to leverage the advantages of resource integration, improve the level of service to customers, and strive to reach the optimal convergence point of customers' real needs.
In 2018, Nyhet International Co., Ltd. successively conducted R&D experiments on cell encapsulation viability and other areas with domestic medical universities, establishing the capacity of NT carry+ technology (cell biomimetic carrier) and achieving an innovative model that allows cells to be transported at room temperature; meanwhile, in 2019, the company defined various specifications of the NT carry+ technology, while simultaneously developing related technologies and branding with its technical team. In 2020, the company was honored with the "17th National Innovation Award - Startup Company," receiving high recognition. Nyhet International Co., Ltd. not only possesses robust R&D capabilities but also promotes the application of this technology in the life science fields of pet medical care and medical beauty and skincare. The company actively strives to be not just a biomedical company with a high price-to-dream ratio, but an innovative enterprise where technology is solidly implemented, becoming the most valuable provider in this industry chain. This allows development strategies at different stages to leverage the advantages of resource integration, improve the level of service to customers, and strive to reach the optimal convergence point of customers' real needs.
The content above was translated by Ai
